Carterra | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Carterra is a biotechnology company focused on high-throughput technologies that enhance the discovery and characterization of therapeutic candidates, particularly monoclonal antibodies and small molecules. The company utilizes patented microfluidics and real-time High Throughput Surface Plasmon Resonance (HT-SPR) instruments, which allow for significantly increased throughput and reduced sample usage compared to traditional methods.

Flagship products include the LSA®, LSA XT®, and Ultra™ platforms, designed for rapid and sensitive biophysical characterization. These platforms support antibody screening and small molecule drug discovery, with the Ultra platform offering enhanced sensitivity for fragment and small molecule applications. Carterra also provides advanced software solutions for kinetic and epitope analysis, as well as specialized consumables to optimize instrument performance. Their technologies are widely adopted by leading pharmaceutical companies and academic institutions to accelerate drug discovery and development processes.